Tag: Vaccines
Omicron Resists Pfizer Vaccine but Causes Less Severe Disease
Risk for hospital admission among adults with COVID-19 29 percent lower than in the first pandemic wave that began in March 2020
mRNA-1273 Has High Vaccine Effectiveness After Five Months
Vaccine effectiveness 87.4 percent against COVID-19 infection, and 95.8 and 97.9 percent against COVID-19 hospitalization, hospital death
mRNA-1273, BNT162b2 Vaccines Comparable for Lowering COVID-19 Risk
mRNA-1273 marginally more effective than BNT162b2 among U.S. veterans, but risk for outcomes at 24 weeks low with both vaccines
Almost One-Third of Mumps Cases in U.S. Occur in Children, Teens
Median of 87 percent of the pediatric patients each year had previously received one or more MMR vaccine dose
Concurrent Zoster, Flu Vaccines Tied to Lower Subsequent Flu Vaccine Uptake
Patients may misattribute adverse effects commonly caused by the zoster vaccine to the influenza vaccine
Childhood Vaccination Schedule Not Linked to Type 1 Diabetes
Recommended immunization schedule is not positively associated with the incidence of type 1 diabetes in children
Pfizer to Seek FDA Approval of Boosters for Teens Ages 16 to 17
Move to expand booster availability comes as President Joe Biden tries to keep Americans calm about omicron
Cervical Cancer Deaths Down Following HPV Vaccine Introduction
Reductions in cervical cancer incidence, mortality in the U.S. greater for those aged 15 to 24 years than those aged 25 to 29, 30 to 39 years
SARS-CoV-2 Infection Up >90 Days Since Second BNT162b2 Dose
Individuals who tested positive for SARS-CoV-2 had significantly longer time elapsed since vaccine injection
Vaccine Makers Already Testing Their Shots Against Omicron Variant
So far, existing vaccines have proven effective against prior coronavirus variants, including the delta variant
